- Home
- INDP vs SSY Comparison
INDP vs SSY Comparison
Compare INDP & SSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- SSY
- Stock Information
- Founded
- INDP 2000
- SSY 1959
- Country
- INDP United States
- SSY United States
- Employees
- INDP N/A
- SSY N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- SSY Hospital/Nursing Management
- Sector
- INDP Health Care
- SSY Health Care
- Exchange
- INDP Nasdaq
- SSY Nasdaq
- Market Cap
- INDP 7.4M
- SSY 6.3M
- IPO Year
- INDP N/A
- SSY N/A
- Fundamental
- Price
- INDP $0.45
- SSY $0.83
- Analyst Decision
- INDP Strong Buy
- SSY
- Analyst Count
- INDP 2
- SSY 0
- Target Price
- INDP $8.50
- SSY N/A
- AVG Volume (30 Days)
- INDP 43.0K
- SSY 8.5K
- Earning Date
- INDP 05-14-2025
- SSY 05-13-2025
- Dividend Yield
- INDP N/A
- SSY N/A
- EPS Growth
- INDP N/A
- SSY N/A
- EPS
- INDP N/A
- SSY 0.25
- Revenue
- INDP N/A
- SSY $31,094,000.00
- Revenue This Year
- INDP N/A
- SSY N/A
- Revenue Next Year
- INDP N/A
- SSY N/A
- P/E Ratio
- INDP N/A
- SSY $3.51
- Revenue Growth
- INDP N/A
- SSY N/A
- 52 Week Low
- INDP $0.43
- SSY $0.53
- 52 Week High
- INDP $3.10
- SSY $1.91
- Technical
- Relative Strength Index (RSI)
- INDP 44.18
- SSY 40.61
- Support Level
- INDP $0.36
- SSY $0.82
- Resistance Level
- INDP $0.48
- SSY $0.87
- Average True Range (ATR)
- INDP 0.05
- SSY 0.04
- MACD
- INDP 0.01
- SSY -0.01
- Stochastic Oscillator
- INDP 59.80
- SSY 3.16
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.
About SSY SunLink Health Systems Inc.
SunLink Health Systems Inc is engaged in providing retail pharmacy services. The company operates its business through segments namely the Healthcare Services segment and Pharmacy segment. The Healthcare Services segment includes subsidiaries that own and operate licensed-bed, acute care hospitals, which includes bed geriatric psychology unit, and nursing home; own medical buildings, which are leased to unaffiliated healthcare providers, and adjacent vacant land; and provides information technology to outside customers. The Pharmacy segment, which is the key revenue generator is composed of retail pharmacy products and services that are conducted in rural markets; institutional pharmacy services; pharmacy services; and durable medical equipment.